E. ÖZKAN Et Al. , "Evaluation of chemocine reseptor 4 expression by 68Ga Pentixafor PET/CT in patients with multiple myeloma," 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , vol.45, Düsseldorf, Germany, 2018
ÖZKAN, E. Et Al. 2018. Evaluation of chemocine reseptor 4 expression by 68Ga Pentixafor PET/CT in patients with multiple myeloma. 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , (Düsseldorf, Germany).
ÖZKAN, E., SOYDAL, Ç., Sahin, U., KÜÇÜK, N. Ö., Beksac, M., Ozturk, C., ... CİVRİZ BOZDAĞ, S.(2018). Evaluation of chemocine reseptor 4 expression by 68Ga Pentixafor PET/CT in patients with multiple myeloma . 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany
ÖZKAN, ELGİN Et Al. "Evaluation of chemocine reseptor 4 expression by 68Ga Pentixafor PET/CT in patients with multiple myeloma," 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 2018
ÖZKAN, ELGİN Et Al. "Evaluation of chemocine reseptor 4 expression by 68Ga Pentixafor PET/CT in patients with multiple myeloma." 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Düsseldorf, Germany, 2018
ÖZKAN, E. Et Al. (2018) . "Evaluation of chemocine reseptor 4 expression by 68Ga Pentixafor PET/CT in patients with multiple myeloma." 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Düsseldorf, Germany.
@conferencepaper{conferencepaper, author={ELGİN ÖZKAN Et Al. }, title={Evaluation of chemocine reseptor 4 expression by 68Ga Pentixafor PET/CT in patients with multiple myeloma}, congress name={31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)}, city={Düsseldorf}, country={Germany}, year={2018}}